+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Retinal Drugs Market 2021-2025- Product Image

Global Retinal Drugs Market 2021-2025

  • ID: 5305726
  • Report
  • March 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • AbbVie Inc.
  • Alcon Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Retinal Drugs Market 2021-2025

The publisher has been monitoring the retinal drugs market and it is poised to grow by $ 6.28 bn during 2021-2025, progressing at a CAGR of 6% during the forecast period. The report on retinal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rise in the prevalence of retinal diseases, emergence of advanced diagnostic tools, and patient assistance programs. In addition, a rise in the prevalence of retinal diseases is anticipated to boost the growth of the market as well.

The retinal drugs market analysis includes indication segment and geographical landscapes.

The retinal drugs market is segmented as below:

By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
By Indication
  • Macular degeneration
  • Diabetic eye disease
  • others
This study identifies the development of innovative therapies as one of the prime reasons driving the retinal drugs market growth during the next few years. Also, a rise in demand for sustained-release ocular formulations and advancement in diagnostic techniques will lead to sizable demand in the market.

The report on retinal drugs market covers the following areas:
  • Retinal drugs market sizing
  • Retinal drugs market forecast
  • Retinal drugs market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading retinal drugs market vendors that include AbbVie Inc., Aerie Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd. Also, the retinal drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Alcon Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Indication
  • Market segments
  • Comparison by Indication
  • Macular degeneration - Market size and forecast 2020-2025
  • Diabetic eye disease - Market size and forecast 2020-2025
  • Others - Market size and forecast 2020-2025
  • Market opportunity by Indication
Segmentation by Drug Class
  • Anti-VEGF agents
  • Corticosteroids
  • Others
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Aerie Pharmaceuticals Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ billion)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Other1 - Market share 2020-2025 (%)
  • Comparison by Other1
  • Macular degeneration - Market size and forecast 2020-2025 ($ billion)
  • Macular degeneration - Year-over-year growth 2020-2025 (%)
  • Diabetic eye disease - Market size and forecast 2020-2025 ($ billion)
  • Diabetic eye disease - Year-over-year growth 2020-2025 (%)
  • Others - Market size and forecast 2020-2025 ($ billion)
  • Others - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Other1
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ billion)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ billion)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ billion)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ billion)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ billion)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Aerie Pharmaceuticals Inc. - Overview
  • Aerie Pharmaceuticals Inc. - Business segments
  • Aerie Pharmaceuticals Inc. - Key offerings
  • Aerie Pharmaceuticals Inc. - Key customers
  • Aerie Pharmaceuticals Inc. - Segment focus
  • Alcon Inc. - Overview
  • Alcon Inc. - Business segments
  • Alcon Inc. - Key offerings
  • Alcon Inc. - Key customers
  • Alcon Inc. - Segment focus
  • Bausch Health Companies Inc. - Overview
  • Bausch Health Companies Inc. - Business segments
  • Bausch Health Companies Inc. - Key offerings
  • Bausch Health Companies Inc. - Key customers
  • Bausch Health Companies Inc. - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Otsuka Holdings Co. Ltd. - Overview
  • Otsuka Holdings Co. Ltd. - Business segments
  • Otsuka Holdings Co. Ltd. - Key offerings
  • Otsuka Holdings Co. Ltd. - Key customers
  • Otsuka Holdings Co. Ltd. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Regeneron Pharmaceuticals Inc. - Overview
  • Regeneron Pharmaceuticals Inc. - Product and service
  • Regeneron Pharmaceuticals Inc. - Key offerings
  • Regeneron Pharmaceuticals Inc. - Key customers
  • Regeneron Pharmaceuticals Inc. - Segment focus
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Key customers
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Alcon Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
The publisher recognizes the following companies as the key players in the global retinal drugs market: AbbVie Inc., Aerie Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is development of innovative therapies.'

According to the report, one of the major drivers for this market is the rise in prevalence of retinal diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Aerie Pharmaceuticals Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll